BOSTON, MA – Halloran Consulting Group, the life science management consulting firm, expands its robust range of clinical finance capabilities with the addition of the industry’s leading financial forecasting tool.
Halloran’s clinical finance services for medical device, pharmaceutical, biotech, and service clients include early scenario planning, detailed study cost estimates, and accruals management. Halloran combines clinical budget-building expertise with the power of a tool that houses extensive clinical intelligence and industry financial benchmarking data. Clients benefit from rapid, extremely detailed, and unfailingly accurate estimates, allowing them to identify candidates for cost reduction, obtain clear guidance on “what if” scenarios, and optimize R&D spending. Halloran’s new technology also provides value mid-study, reforecasting costs for protocol amendments and changes to scope with increased speed and accuracy, reducing financial surprises for their clients.
“Halloran’s vigorous clinical financial services provide tremendous value to clients, but with the addition of this financial forecasting tool, we take our precision to the next level,” reports Laurie Halloran, President and CEO. “This new technology changes the landscape entirely, producing clinical study budgets that require less investment of energy, time, and money, and allows clinical trial managers and investors to be confident in the allocation of spend. By partnering with Halloran for their clinical finance needs, companies gain data-driven financial planning capabilities with 95-99% accuracy and save in terms of vendor cost, fewer surprises mid- or post-study, and increased time to focus on other matters.”
Halloran’s advanced capabilities are structured to fit the demands of an area that is a significant pain point for many organizations in the life science industry. Through expertise in the field, extensive benchmarking data, automated management tools, and now a leading forecasting tool, Halloran offers streamlined, comprehensive solutions for study, program, and portfolio financial planning and management.
About Halloran Consulting Group
Halloran Consulting Group is a management consulting firm that partners with life science companies to guide them through today’s complex clinical landscape. Halloran works with industry organizations of all types, including biotech, pharma, medical device, and life science service providers, to streamline procedures and maximize available resources. Halloran provides on-demand expertise to complement development teams and fills gaps in clinical, regulatory, quality, and program management capabilities. For more information, please visit hallorancg.com.
Halloran Corporate Contact:
Halloran Consulting Group, Inc.